Bugworks: GARDP Supports Bugworks In Assessing Safety Of New Antibiotic Compound
9 June 2022 - The Global Antibiotic Research and Development Partnership (GARDP) and Bugworks, a key player in the global antimicrobial resistance (AMR) innovation ecosystem, are collaborating o...
Read full article »
Bugworks is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and infectious diseases.
Read more